Physician profile
James Lee
NPI 1669819116
$3,622.69
in general payments reported to CMS, 2019-2025
10 companies · $2,828 in 2025
The $2,828 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $413 · 2021: $72.16 · 2022: $156 · 2023: $71.77 · 2024: $81.92 · 2025: $2,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $481.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $2,771.52 | 2025 | |
| Synthes Gmbh | $412.60 | 2020 | |
| Sientra, INC. | $136.09 | 2021-2022 | |
| Integra Lifesciences Corporation | $103.54 | 2022-2024 | Integra, Surgimend, Omnigraft |
| Abbvie INC. | $59.03 | 2023-2024 | |
| Abbott Laboratories | $30.77 | 2023 | |
| Organogenesis INC. | $30.35 | 2022 | |
| Avita Medical Americas, LLC | $29.27 | 2025 | Permeaderm, Recell, Cohealyx |
| Tela Bio, INC. | $27.00 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $22.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.